Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 31722-443

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 31722-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eletriptan20mgcarton (Eletriptan20mgcarton)

Eletriptan20mgcarton (Eletriptan20mgcarton)
This text describes Eletriptan Hydrobromide Tablets containing 20 mg of active ingredient. The tablets are stored between 20° to 25°C and can be kept between 15° to 30°C temporarily. Dosage instructions should be obtained from prescribing information. The package is child-resistant and manufactured by Camber Pharmaceuticals for Annora Pharma Pt. Ltd. Contact information for US queries is provided.*
FDA Label Image

Eletriptan40mgcarton (Eletriptan40mgcarton)

Eletriptan40mgcarton (Eletriptan40mgcarton)
This is a prescription medication labeled as Eletriptan Hydrobromide Tablets. The package contains 6 unit-dose tablets. The contact number for inquiries is 1-866-455-1995. The medication is manufactured by Annora Pharma Pvt. Ltd. It is important to follow the prescribing information provided with the package.*
FDA Label Image

Eletriptanfigure2 (Eletriptanfigure2)

FDA Label Image
FDA Label Image

Eletriptanstructure (Eletriptanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.